Report Detail

Pharma & Healthcare Global Live-type Poultry Vaccine Market Research Report 2022

  • RnM4454472
  • |
  • 16 June, 2022
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.
Industry Insights

Due to the COVID-19 pandemic, the global Live-type Poultry Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Live-type Poultry Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Live-type Poultry Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Newcastle Disease Vaccine accounting for % of the Live-type Poultry Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Chicken segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Live-type Poultry Vaccine include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. In terms of revenue, the global 3 largest players have a % market share of Live-type Poultry Vaccine in 2021.

This report focuses on Live-type Poultry Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Live-type Poultry Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Live-type Poultry Vaccine market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Newcastle Disease Vaccine

Infectious Bronchitis Vaccine

Fowl Pox Vaccine

Marek’s Disease Vaccine

Fowl Typhoid Vaccine

Live Coccidiosis Vaccine

Other

Segment by Application

Chicken

Other Poultry

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

MERCK

Boehringer Ingelheim

ELANCO

QYH BIOTECH

CEVA

ZOETIS

Vaxxinova

PULIKE

PHIBRO ANIMAL HEALTH CORPORATION

JINYU BIOTECHNOLOGY

HARBIN PHARMACEUTICAL GROUP

MEVAC

Frequently Asked Questions

Which product segment grabbed the largest share in the Live-type Poultry Vaccine market?

How is the competitive scenario of the Live-type Poultry Vaccine market?

Which are the key factors aiding the Live-type Poultry Vaccine market growth?

Which are the prominent players in the Live-type Poultry Vaccine market?

Which region holds the maximum share in the Live-type Poultry Vaccine market?

What will be the CAGR of the Live-type Poultry Vaccine market during the forecast period?

Which application segment emerged as the leading segment in the Live-type Poultry Vaccine market?

What key trends are likely to emerge in the Live-type Poultry Vaccine market in the coming years?

What will be the Live-type Poultry Vaccine market size by 2028?

Which company held the largest share in the Live-type Poultry Vaccine market?


1 Live-type Poultry Vaccine Market Overview

  • 1.1 Product Overview and Scope of Live-type Poultry Vaccine
  • 1.2 Live-type Poultry Vaccine Segment by Type
  • 1.2.1 Global Live-type Poultry Vaccine Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Newcastle Disease Vaccine
  • 1.2.3 Infectious Bronchitis Vaccine
  • 1.2.4 Fowl Pox Vaccine
  • 1.2.5 Marek’s Disease Vaccine
  • 1.2.6 Fowl Typhoid Vaccine
  • 1.2.7 Live Coccidiosis Vaccine
  • 1.2.8 Other
  • 1.3 Live-type Poultry Vaccine Segment by Application
  • 1.3.1 Global Live-type Poultry Vaccine Sales Comparison by Application: (2022-2028)
  • 1.3.2 Chicken
  • 1.3.3 Other Poultry
  • 1.4 Global Live-type Poultry Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Live-type Poultry Vaccine Revenue 2017-2028
  • 1.4.2 Global Live-type Poultry Vaccine Sales 2017-2028
  • 1.4.3 Live-type Poultry Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Live-type Poultry Vaccine Market Competition by Manufacturers

    • 2.1 Global Live-type Poultry Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Live-type Poultry Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Live-type Poultry Vaccine Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Live-type Poultry Vaccine Manufacturing Sites, Area Served, Product Type
    • 2.5 Live-type Poultry Vaccine Market Competitive Situation and Trends
    • 2.5.1 Live-type Poultry Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Live-type Poultry Vaccine Players Market Share by Revenue
  • 2.5.3 Global Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Live-type Poultry Vaccine Retrospective Market Scenario by Region

    • 3.1 Global Live-type Poultry Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Live-type Poultry Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Live-type Poultry Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Live-type Poultry Vaccine Sales by Country
  • 3.3.2 North America Live-type Poultry Vaccine Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Live-type Poultry Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Live-type Poultry Vaccine Sales by Country
  • 3.4.2 Europe Live-type Poultry Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Live-type Poultry Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Live-type Poultry Vaccine Sales by Region
  • 3.5.2 Asia Pacific Live-type Poultry Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Live-type Poultry Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Live-type Poultry Vaccine Sales by Country
  • 3.6.2 Latin America Live-type Poultry Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Live-type Poultry Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Live-type Poultry Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Live-type Poultry Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Live-type Poultry Vaccine Historic Market Analysis by Type

    • 4.1 Global Live-type Poultry Vaccine Sales Market Share by Type (2017-2022)
    • 4.2 Global Live-type Poultry Vaccine Revenue Market Share by Type (2017-2022)
    • 4.3 Global Live-type Poultry Vaccine Price by Type (2017-2022)

    5 Global Live-type Poultry Vaccine Historic Market Analysis by Application

    • 5.1 Global Live-type Poultry Vaccine Sales Market Share by Application (2017-2022)
    • 5.2 Global Live-type Poultry Vaccine Revenue Market Share by Application (2017-2022)
    • 5.3 Global Live-type Poultry Vaccine Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 MERCK
    • 6.1.1 MERCK Corporation Information
  • 6.1.2 MERCK Description and Business Overview
  • 6.1.3 MERCK Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 MERCK Live-type Poultry Vaccine Product Portfolio
  • 6.1.5 MERCK Recent Developments/Updates
  • 6.2 Boehringer Ingelheim
  • 6.2.1 Boehringer Ingelheim Corporation Information
  • 6.2.2 Boehringer Ingelheim Description and Business Overview
  • 6.2.3 Boehringer Ingelheim Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Boehringer Ingelheim Live-type Poultry Vaccine Product Portfolio
  • 6.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.3 ELANCO
  • 6.3.1 ELANCO Corporation Information
  • 6.3.2 ELANCO Description and Business Overview
  • 6.3.3 ELANCO Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 ELANCO Live-type Poultry Vaccine Product Portfolio
  • 6.3.5 ELANCO Recent Developments/Updates
  • 6.4 QYH BIOTECH
  • 6.4.1 QYH BIOTECH Corporation Information
  • 6.4.2 QYH BIOTECH Description and Business Overview
  • 6.4.3 QYH BIOTECH Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 QYH BIOTECH Live-type Poultry Vaccine Product Portfolio
  • 6.4.5 QYH BIOTECH Recent Developments/Updates
  • 6.5 CEVA
  • 6.5.1 CEVA Corporation Information
  • 6.5.2 CEVA Description and Business Overview
  • 6.5.3 CEVA Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 CEVA Live-type Poultry Vaccine Product Portfolio
  • 6.5.5 CEVA Recent Developments/Updates
  • 6.6 ZOETIS
  • 6.6.1 ZOETIS Corporation Information
  • 6.6.2 ZOETIS Description and Business Overview
  • 6.6.3 ZOETIS Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 ZOETIS Live-type Poultry Vaccine Product Portfolio
  • 6.6.5 ZOETIS Recent Developments/Updates
  • 6.7 Vaxxinova
  • 6.6.1 Vaxxinova Corporation Information
  • 6.6.2 Vaxxinova Description and Business Overview
  • 6.6.3 Vaxxinova Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Vaxxinova Live-type Poultry Vaccine Product Portfolio
  • 6.7.5 Vaxxinova Recent Developments/Updates
  • 6.8 PULIKE
  • 6.8.1 PULIKE Corporation Information
  • 6.8.2 PULIKE Description and Business Overview
  • 6.8.3 PULIKE Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 PULIKE Live-type Poultry Vaccine Product Portfolio
  • 6.8.5 PULIKE Recent Developments/Updates
  • 6.9 PHIBRO ANIMAL HEALTH CORPORATION
  • 6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
  • 6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
  • 6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product Portfolio
  • 6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
  • 6.10 JINYU BIOTECHNOLOGY
  • 6.10.1 JINYU BIOTECHNOLOGY Corporation Information
  • 6.10.2 JINYU BIOTECHNOLOGY Description and Business Overview
  • 6.10.3 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product Portfolio
  • 6.10.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
  • 6.11 HARBIN PHARMACEUTICAL GROUP
  • 6.11.1 HARBIN PHARMACEUTICAL GROUP Corporation Information
  • 6.11.2 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Description and Business Overview
  • 6.11.3 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product Portfolio
  • 6.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
  • 6.12 MEVAC
  • 6.12.1 MEVAC Corporation Information
  • 6.12.2 MEVAC Live-type Poultry Vaccine Description and Business Overview
  • 6.12.3 MEVAC Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 MEVAC Live-type Poultry Vaccine Product Portfolio
  • 6.12.5 MEVAC Recent Developments/Updates
  • 7 Live-type Poultry Vaccine Manufacturing Cost Analysis

    • 7.1 Live-type Poultry Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Live-type Poultry Vaccine
  • 7.4 Live-type Poultry Vaccine Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Live-type Poultry Vaccine Distributors List
    • 8.3 Live-type Poultry Vaccine Customers

    9 Live-type Poultry Vaccine Market Dynamics

    • 9.1 Live-type Poultry Vaccine Industry Trends
    • 9.2 Live-type Poultry Vaccine Market Drivers
    • 9.3 Live-type Poultry Vaccine Market Challenges
    • 9.4 Live-type Poultry Vaccine Market Restraints

    10 Global Market Forecast

    • 10.1 Live-type Poultry Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Live-type Poultry Vaccine by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Type (2023-2028)
  • 10.2 Live-type Poultry Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Live-type Poultry Vaccine by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Application (2023-2028)
  • 10.3 Live-type Poultry Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Live-type Poultry Vaccine by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Live-type Poultry Vaccine. Industry analysis & Market Report on Live-type Poultry Vaccine is a syndicated market report, published as Global Live-type Poultry Vaccine Market Research Report 2022. It is complete Research Study and Industry Analysis of Live-type Poultry Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,401.20
      4,802.40
      2,781.10
      5,562.20
      392,573.00
      785,146.00
      228,984.00
      457,968.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report